Introduction: vascular endothelial growth factor (VEGF) and tumour necrosis factor alpha (TNF ) have been specifically implicated in the tissue damage associated with chronic venous disease (CVD
Introduction
compression is thought to promote ulcer healing by acting to restore venous tone, reducing reflux and ambulatory venous pressures and normalising the venChronic venous disease is the commonest but least ous haemodynamics. 5 Multilayer bandaging systems understood cause of lower leg ulceration. The tissue based on the Charing Cross model achieve the greatest changes and ulceration which develop in patients with level of sustained graduated pressure and are accepted chronic venous disease (CVD) are strongly correlated as effective methods of promoting healing of venous with elevated ambulatory pressures (AVP) in the suulcers. 6 perficial veins. 1 A number of theories have attempted Recently, in vivo studies of systemic essential hyperto explain this association. Accumulation and actension, 7 pre-eclampsia 8 and pulmonary hypertension 9 tivation of sequestered white cells in affected limbs have shown an associated elevation in serum cytoforms the basis of the currently favoured theories. 2, 3 kines, notably vascular endothelial growth factor None of these, however, explain the relationship be-(VEGF) and tumour necrosis factor alpha (TNF ). tween elevated AVP and tissue pathology in CVD.
Elevated serum levels of VEGF have also been demThere is as yet no established causative link between onstrated in the limbs of patients with chronic venous venous hypertension and tissue disease. 2 disease (CVD). 10 It has further been shown, using inCompression treatment is the first line therapy for vitro models, that endothelial cells subject to abnormal venous ulcers and is effective in achieving healing of sheer forces and hypertension display altered function ulcers in the majority of patients. Patients with smaller and cytokine secretion. [11] [12] [13] [14] [15] This is accomplished ulcers present for shorter durations have the greatest through a process of mechanotransduction, the mechresponse to this treatment and healing rates of up to anism whereby cells transduce mechanical stimuli into 95% have been reported in these groups. 4 Graduated an intracellular signal and biological response. 13 There is as yet no published data on the effect of venous hypertension on cytokine secretion from the vascular during the treatment period. The repeat samples were taken after between 4 and 6 weeks of treatment with 4-layered graduated compression when the ulcers exIt is our hypothesis that superficial venous hyperhibited healing. This time point was chosen, as it is tension produces in a local alteration in cytokine prothe timeframe in which a positive response to therapy duction resulting in an alteration of the cytokine has been shown to manifest as a reduction in ulcer content of the microcirculation, tissues and wound size. 4 Patients who demonstrate reduction in ulcer size microenvironment in limbs with CVD. We further at this point are those in whom compression therapy is hypothesise that these changes are reversible upon effective as a method of treatment. This is presumably reduction of venous hypertension with compression because this group of patients represents those who treatment.
are compliant and whose venous haemodynamics are A number of cytokines with established roles in beneficially altered by compression. Healing was angiogenesis and wound healing are among those measured as a reduction in ulcer size using comwhose production have been shown to be stimulated puterised planimetry. Patients with varicose veins only by elevated pressures. From the currently available had single samples taken. In these patients serum data those cytokines which are likely to be of importsamples were taken from superficial varicosities in the ance in CVD include VEGF and TNF .
distribution of the LSV in the lower leg. The aim of this study was to determine the serum In all sampling groups control samples from the levels of VEGF and TNF in the superficial veins of patients' median cubital vein were taken simpatients with venous ulceration at first presentation ultaneously to serve as controls. Blood samples were and again after a period of treatment with 4-layer collected in plain tubes and centrifuged at 2000 rpm graduated compression.
for 10 min to obtain serum fraction. Samples were then stored at −80°C until assayed.
Methods

Cytokine ELISA Patient selection
Determination of the concentrations of VEGF and Ethical approval for this study was granted by the TNF proteins were performed with sandwich enNorth Eastern Health Board of Ireland. Eight patients zyme-linked immunosorbent assays (R&D Systems, with non-healing ulcers were selected from a spe-U.K.). The assays were performed according to the cialised ulcer clinic before institution of treatment. manufacturer's protocol. Results were obtained from Patients were excluded if they evidence of peripheral an ELISA reader and calculated using statistical softarterial disease as determined by ankle brachial pres-ware programme "Analyse-it for Microsoft Excel", sure indices (ABIs) of <0.8. Patients with diabetes or Leeds, U.K. Statistical analyses were carried out using rheumatoid disease were also excluded.
the Wilcoxin Signed Ranks test. p values of <0.05 were All patients had duplex confirmed CVD. Venous considered significant. reflux was determined using a Hewlett Packard Sonos 500 scanner with venous imaging software. Reflux was defined as reversed flow lasting greater than 0.5 s in Results the superficial, deep or perforator veins according to recent consensus guidelines. 16 All eight patients (5 male/3 female) with venous ulcers completed the study. In all cases patients exhibited Ulcer size ranged from 1-5 cm 2 and had been present for a median of 6 months (Table 1) .
healing as determined by a reduction in the ulcer at the time of repeat sampling. All ulcers had completely A further group of 8 patients presenting with var-of both VEGF to below control values with treatment (Figs 1 and 2) .
Serum from patients with varicose veins but no ulceration (CEAP 2) also showed elevations in the levels of VEGF cytokines in all cases (Fig. 1) . TNF levels in varicose vein patients were also elevated but failed to reach statistical significance compared to the systemic controls at the start of treatment (Fig. 2) .
Discussion
This study, for the first time, demonstrates a significant elevation in VEGF and TNF in patients presenting with venous ulceration and shows that these levels is considered that this cytokine was originally named Vascular Permeability Factor because of its potent effect on the permeability of the vascular wall. Increased vascular permeability may play an important role in tissue oedema, fibrin deposition and lipodermatosclerosis in CVD.
TNF is a well-characterised cytokine which has been strongly implicated in tissue damage associated with CVD.
17 Endothelial cells can be stimulated to produce TNF.
18 Serum TNF is increased in hypertensive states including essential hypertension and pre-eclampsia. TNF not only inhibits the growth of endothelial cells in vitro but has been demonstrated to selectively inhibit the pro-angiogenic effect of VEGF and synergistically increase its effect on permeability. 19, 20 Furthermore, it inhibits anti-coagulatory mechanisms and promotes thrombotic processes and therefore plays an important role in pathological processes such as venous thromboses.
The study demonstrates an abnormal cytokine environment in the serum of patients with venous ulceration and a reversal with successful therapy. The as an intracellular biological response to altered mechanical forces, suggest hypertension induced mechanotransduction as a potential source of cytokines re-epithelialised within 8 weeks of samples taken in the healing phase (Table 1) . in these conditions. Our conclusions are based on venous ulceration occurring as a consequence of inAll patients had significantly elevated levels of VEGF in samples during the non-healing phase (Fig. 1) . creased pressure in the superficial veins and healing of ulceration being promoted by effective reduction Similarly, TNF was elevated in non-healing samples (Fig. 2) .In each case there was a reduction in the levels of these elevated pressures. The study hypothesis at-tempts to provide an explanation of how the hyper-regulation of cytokine production in hypertensive veins will be necessary to establish this metension might cause inflammatory changes and ulchanotransduction as a causative factor in the tissue ceration in the tissues. Both of the cytokines measured damage associated with CVD. in this are recognised as having important effects on mediating inflammation and in the regulation of wound healing. Release of vasoactive and inflammatory mediators such as VEGF and TNF in References
